Concepedia

Ronald Emkey

RE

29

Publications

6.5K

Citations

27

H-Index

1973

Active since

Affiliations

Radiant Research (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Reading Hospital

Hôpital Edouard Herriot

Altoona Arthritis and Osteoporosis Center

Ronald Emkey is an author at Radiant Research (United States) specializing in medicine, bone health, and osteoporosis.

Top concepts

Publications per year

1973–2019

29

Publications

29

Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer et al. · New England Journal of Medicine · 2004 · 1.3K citations · Full text

Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Kenneth G. Saag, Ronald Emkey, Thomas J. Schnitzer et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text

Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Stanley Cohen, Robert M. Levy, Michael Keller et al. · Arthritis & Rheumatism · 1999 · 615 citations

Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women<sup>1</sup>

Richard P. Tonino, Pierre J. Meunier, Ronald Emkey et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 337 citations

, , +17

The Efficacy and Tolerability of Risedronate Once a week for the Treatment of Postmenopausal Osteoporosis

Jacques P. Brown, David L. Kendler, Michael R. McClung et al. · Calcified Tissue International · 2002 · 334 citations

, , +6

Rows per page

1–5 of 29